about
Perivascular delivery of Notch 1 siRNA inhibits injury-induced arterial remodelingThe δA isoform of calmodulin kinase II mediates pathological cardiac hypertrophy by interfering with the HDAC4-MEF2 signaling pathwayEffects of RNA silencing of matrix metalloproteinase-2 on the growth of esophageal carcinoma cells in vivoLiposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures.Non-condensing polymeric nanoparticles for targeted gene and siRNA deliveryCarrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group.Surface-modified HK:siRNA nanoplexes with enhanced pharmacokinetics and tumor growth inhibition.Zinc Finger Nucleases: Tailor-made for Gene TherapyInnovative pharmaceutical development based on unique properties of nanoscale delivery formulation.Acid-Sensitive Sheddable PEGylated PLGA Nanoparticles Increase the Delivery of TNF-α siRNA in Chronic Inflammation Sites.Peptides used in the delivery of small noncoding RNA.Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy.Development of streptavidin-based nanocomplex for siRNA delivery.A Combination RNAi-Chemotherapy Layer-by-Layer Nanoparticle for Systemic Targeting of KRAS/P53 with Cisplatin to Treat Non-small Cell Lung Cancer.Small-interfering RNA-eluting surfaces as a novel concept for intravascular local gene silencing.Lipopeptide delivery of siRNA to the central nervous system.Complex formation between polyelectrolytes and oppositely charged oligoelectrolytes.Cellular Antisense Activity of PNA-Oligo(bicycloguanidinium) Conjugates Forming Self-Assembled Nanoaggregates.Polymeric micelles for MCL-1 gene silencing in breast tumors following systemic administration.
P2860
Q27335763-DF41BB6C-BCA0-4661-B23C-D418E982F0B9Q28582985-74FE989C-A7C8-4920-A8D8-083B17030AC2Q33598470-BC616381-62AB-4B68-B39B-69E61C67544BQ33608651-64DF4651-F23E-469C-B2EC-F55D64D6F5D6Q35190149-928FF7A1-E56C-46C9-9951-163919880124Q35823611-16FEE9A8-C128-4C4F-AF22-97FCBBBD31A2Q36678913-3C329217-9BF2-4DFB-BEE1-27C833EB0206Q37241457-90237144-9034-457B-8F81-D17D02751DDAQ37602017-3D5D77C8-8AC9-463A-9A8F-15FEFA4A9F81Q37672324-7DE9D7AF-45D3-45A5-B973-5878F6191516Q38243361-19C9FE54-4793-47DF-9BBA-C16B5544EFBAQ38930049-60C5A1E1-8785-4958-AB00-F329B8D44EFFQ39070514-76DF7316-3A0E-47B1-8CED-AC753E1DEEDFQ40040290-90B7ACCA-9B49-4035-B68A-526D8ACD2D0AQ41809791-C4E9C219-0C34-4132-922D-A8E7C58F0FB1Q46250876-536121E1-61E1-4CFC-BA97-08174F7E66C4Q46555401-D3D6C0D3-6693-4FE7-8505-2C4B5D215298Q48798795-ED54325A-C8F6-478B-BE2E-C8DAA344A058Q51198916-670B8228-7707-460F-B78E-7111FB2CFD15
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Advances in Systemic siRNA Delivery
@ast
Advances in Systemic siRNA Delivery
@en
type
label
Advances in Systemic siRNA Delivery
@ast
Advances in Systemic siRNA Delivery
@en
prefLabel
Advances in Systemic siRNA Delivery
@ast
Advances in Systemic siRNA Delivery
@en
P2093
P2860
P1433
P1476
Advances in Systemic siRNA Delivery
@en
P2093
A James Mixson
Martin C Woodle
Patrick Y Lu
Qixin Leng
P2860
P356
10.1358/DOF.2009.034.09.1413267
P577
2009-09-01T00:00:00Z